Published in
American Medical Association, Archives of Internal Medicine -New Series-, 10(172)
DOI: 10.1001/archinternmed.2012.402
Links
- ORCID
- ORCID
- ORCID
- ORCID
- ORCID
- American Medical Association | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [boris.unibe.ch]
- [serval.unil.ch] | PDF
- [europepmc.org] | PDF
- [serval.unil.ch] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [my.unil.ch] | PDF
Tools
Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality
Journal article published in 2012 by
Tinh-Hai Collet 
,
Jacobijn Gussekloo,
Collet Th,
Douglas C. Bauer,
Wendy P. J. den Elzen,
W. P. J. Den Elzen,
Anne R. Cappola,
Bauer Dc,
Philippe Balmer,
Giorgio Iervasi,
Bjørn O. Åsvold,
den Elzen Wp,
Cappola Ar,
José A. Sgarbi ,
Henry Völzke
and other authors.
,
Jacobijn Gussekloo,
Collet Th,
Douglas C. Bauer,
Wendy P. J. den Elzen,
W. P. J. Den Elzen,
Anne R. Cappola,
Bauer Dc,
Philippe Balmer,
Giorgio Iervasi,
Bjørn O. Åsvold,
den Elzen Wp,
Cappola Ar,
José A. Sgarbi ,
Henry Völzke
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Data from prospective cohort studies regarding the association between subclinical hyperthyroidism and cardiovascular outcomes are conflicting.We aimed to assess the risks of total and coronary heart disease (CHD) mortality, CHD events, and atrial fibrillation (AF) associated with endogenous subclinical hyperthyroidism among all available large prospective cohorts.